Answers are grounded in this paper and cite their sources.
High plasma homocysteine is a risk factor for retinal vascular occlusive disease so it may be useful to measure homocysteine in the management of these patients. A randomized, controlled trial is required to study the effect of lowering with homocysteine folic acid and other B vitamins on the risk of recurrent vascular occlusion in the same eye or its development in the fellow eye.
No takes yet. Share an insight, caveat, or question.
El‐Asrar et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: